Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer

Apostolia Maria Tsimberidou, Jamie V. Shaw, Dejan Juric, Claire Verschraegen, Amy M. Weise, John Sarantopoulos, Gilberto Lopes, John Nemunaitis, Monica Mita, Haeseong Park, Barbara Ellers-Lenz, Hui Tian, Wenyuan Xiong, Remigiusz Kaleta, Razelle Kurzrock

Resultado de la investigación: Articlerevisión exhaustiva

6 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer'. En conjunto forman una huella única.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology